13 RFL's four-hour ED performance was 80.4% in August, below the 26/27 standard of 82%. BH 82.0%, North Mid 73.8%, RFH 79.7% and CFH UTC 99.9%. 75.1% of cancer patients started treatment within 62 days in July, below the 26/27 target of 80%. Faster cancer diagnosis (FDS) performance was 80% and achieved the 80% FDS target. 62.6% of patients were treated within 18 weeks from referral in August, down slightly from 62.7% in August, although the patient waiting list reduced by over 1,700 pathways. The trust reported 52-week breaches reduced by over 200 patients from 1,546 to 1,334. 11.3% of ambulances were seen within 15 minutes in August (BH 10.2%, North Mid 11.7%, RFH 12.1%); this is a decrease from 12.9% in June. 79.2% of patients waited under six weeks for diagnostics in August. The trust remains in the third quartile nationally for benchmarking. Hospital deaths remain lower than expected, with a summary hospital-level mortality indicator (SHMI) of 0.87 for May 2025 – April 2026 (latest data). In August, the Friends and Family Test (FFT) positive response rate exceeded 90% across inpatient, outpatient, and maternity services. The Emergency Department achieved a positive response rate of 79.1%, showing an improvement compared with July. In August, there were 17 C. difficile cases, an increase from 14 in July. There were 35 E. coli bacteraemia cases, increased from 24 in July. There was one MRSA bacteraemia case in July and none in August .
RkJQdWJsaXNoZXIy NTI5NzM=